Sign In
Buy PDSB
$1.08
-0.0800 (-6.90%)
At Close: Jun 03, 2026
PDS Biotechnology Announces Conference Call and Webcast for First Quarter Financial Results
04:15pm, Monday, 26'th Apr 2021
FLORHAM PARK, N.J., April 26, 2021 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel cancer therapies and infectious disease vac
PDS Biotechnology Corporation (PDSB) CEO Frank Bedu-Addo on Q4 2020 Results - Earnings Call Transcript
11:41am, Thursday, 18'th Mar 2021
PDS Biotechnology Corporation (PDSB) CEO Frank Bedu-Addo on Q4 2020 Results - Earnings Call Transcript
PDSB Stock: Why PDS Biotech Is Blasting Higher Today
01:07pm, Thursday, 11'th Mar 2021
PDS Biotech (PDSB) stock is heading higher on Thursday after announcing funding for the company's vaccine for the novel coronavirus. The post PDSB Stock: Why PDS Biotech Is Blasting Higher Today appea
PDSB Stock Price Increases Over 20% Pre-Market: Why It Happened
09:30am, Thursday, 11'th Mar 2021
The stock price of PDS Biotechnology Corp (NASDAQ: PDSB) has increased by over 20% pre-market. This is why it happened.
PDS Biotech Announces that its COVID-19 Vaccine Consortium Received a Commitment from The Ministry of Science, Technology and Innovation of Brazil (MCTI) to fund Clinical Development and Commercialization of a Versamune®-Based COVID-19 Vaccine with an Award of up to Approximately US$60 million
08:30am, Thursday, 11'th Mar 2021
Development and commercialization of novel T-cell activating vaccine to be performed in Brazil by consortium of PDS Biotech, Farmacore Biotechnology and Blanver Farmoquímica Development and commercia
PDS Biotechnology Announces Conference Call and Webcast for Fourth Quarter and Full Year 2020 Financial Results
04:30pm, Monday, 08'th Mar 2021
FLORHAM PARK, N.J., March 08, 2021 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel cancer therapies and infectious disease vac
PDS Biotech Announces Presentations in Upcoming Healthcare Investor Conferences
04:30pm, Wednesday, 03'rd Mar 2021
FLORHAM PARK, N.J., March 03, 2021 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel cancer therapies and infectious disease vac
Brazilian-based Blanver brings depth of expertise in development and commercialization of innovative pharmaceuticals across Latin America Brazilian-based Blanver brings depth of expertise in developme
PDS Biotech Releases White Paper Detailing the Potential of the Versamune® Platform in Overcoming a Major Limitation of Immuno-Oncology
08:30am, Thursday, 14'th Jan 2021
Promotes in-vivo tumor-attacking killer T-cells to facilitate cancer treatment Promotes in-vivo tumor-attacking killer T-cells to facilitate cancer treatment
PDS Biotechnology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
08:30am, Wednesday, 06'th Jan 2021
FLORHAM PARK, N.J., Jan. 06, 2021 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel cancer therapies and infectious disease vacc
PDS Biotech Announces Participation in H.C. Wainwright BioConnect 2021 Virtual Conference
08:45am, Tuesday, 05'th Jan 2021
FLORHAM PARK, N.J., Jan. 05, 2021 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel cancer therapies and infectious disease vacc
PDS Biotechnology Appoints Seth Van Voorhees as Chief Financial Officer
08:30am, Wednesday, 09'th Dec 2020
FLORHAM PARK, N.J., Dec. 09, 2020 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel cancer therapies and infectious disease vacc
Where Do Hedge Funds Stand On PDS Biotechnology Corporation (PDSB)?
02:38pm, Friday, 27'th Nov 2020
Although the masses and most of the financial media blame hedge funds for their exorbitant fee structure and disappointing performance, these investors have proved to have great stock picking abilitie
PDS Biotech Announces New and Broad Versamune® Platform Patent Claims
08:30am, Monday, 16'th Nov 2020
Granted methods patent for Versamune® platform by the United States Patent and Trademark Office Granted methods patent for Versamune® platform by the United States Patent and Trademark Office
PDS Biotech and Farmacore Announce Updates to Co-Development of Versamune®-Based COVID-19 Vaccine
04:05pm, Tuesday, 10'th Nov 2020
PDS0203 prioritized for clinical development by PDS Biotech and Farmacore after successful meeting with Brazilian Drug Regulatory Agency PDS0203 prioritized for clinical development by PDS Biotech and
